Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression

被引：3
|
作者：
Ginetta Collo [1 ,2 ]
Emilio Merlo Pich [3 ,4 ]
机构：
[1] Department of Molecular and Translational Medicine,Section of Pharmacology,University of Brescia
[2] Department of Biomedicine,University of Basel
[3] Neuroscience Therapeutic Area Unit,Takeda Pharmaceuticals International
来源：
Neural Regeneration Research | 2018年 / 13卷 / 04期
关键词：
MEK; ERK; Ketamine enhances structural plasticity in human dopaminergic neurons:possible relevance for treatment-resistant depression; TRD; MDD;
D O I：
暂无
中图分类号：
R749.4 [情感性精神病];
学科分类号：
100205 ;
摘要：
Depression refers to a series of mental health issues characterized by loss of interest and enjoyment in everyday life,low mood and selected emotional,cognitive,physical and behavioral symptoms.Depression is a common disorder,affecting 5–15%of the general population.When diagnosed as major depressive disorder(MDD),patients are currently
引用
收藏
页码：645 / 646
页数：2
相关论文
共 50 条
  • [31] Ketamine for Treatment-Resistant Depression: Ready or Not for Clinical Use?
    Rush, A. John
    AMERICAN JOURNAL OF PSYCHIATRY, 2013, 170 (10): : 1079 - 1081
  • [32] Treatment-Resistant Depression: Program Development for Ketamine Infusion
    Miller, Courtney
    Bolton, Paula
    JOURNAL OF THE AMERICAN PSYCHIATRIC NURSES ASSOCIATION, 2019, 25 (04) : 332 - 332
  • [33] Use of Ketamine in Elderly Patients with Treatment-Resistant Depression
    Carolina Medeiros da Frota Ribeiro
    Patricio Riva-Posse
    Current Psychiatry Reports, 2017, 19
  • [34] Q/Is ketamine effective and safe for treatment-resistant depression?
    Zorn, Amanda
    Linn, Sean
    Jenkinson, Mat
    Neher, Jon O.
    Safranek, Sarah
    Kelsberg, Gary
    JOURNAL OF FAMILY PRACTICE, 2021, 70 (03): : E1 - E3
  • [35] KETAMINE FOR TREATMENT-RESISTANT DEPRESSION: READY FOR CLINICAL TRANSLATION?
    Loo, C. K.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2023, 57 (01): : 10 - 10
  • [36] Efficacy of Ketamine in Treatment-Resistant Depression: An Umbrella Review
    Klassen, Amanda M.
    Baten, Caitlin
    Zamora, Gladys
    Shepherd, Jonah H.
    Johnson-Venegas, Ellie
    Madugula, Sasidhar S.
    Woo, Ellen
    Hamilton, J. Paul
    Miller, Jennifer A.
    Sacchet, Matthew D.
    Hedges, Dawson W.
    Miller, Chris H.
    BIOLOGICAL PSYCHIATRY, 2024, 95 (10) : S198 - S198
  • [37] Biological Perspectives Ketamine as an Alternative Treatment for Treatment-Resistant Depression
    Dowben, Jonathan S.
    Grant, Joan S.
    Keltner, Norman L.
    PERSPECTIVES IN PSYCHIATRIC CARE, 2013, 49 (01) : 2 - 4
  • [38] Remission of Treatment-Resistant Depression With Electroconvulsive Therapy and Ketamine
    Niemegeers, Peter
    Schrijvers, Didier
    Madani, Yamina
    Sabbe, Bernard G. C.
    JOURNAL OF ECT, 2014, 30 (03) : E31 - E32
  • [39] The Downstaging Concept in Treatment-Resistant Depression: Spotlight on Ketamine
    Wilkowska, Alina
    Cubala, Wieslaw Jerzy
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (23)
  • [40] The Effect of Ketamine on Reinforcement Learning in Treatment-Resistant Depression
    Mkrtchian, Anahit
    Lally, Niall
    Nugent, Allison C.
    Evans, Jennifer W.
    Roiser, Jonathan P.
    Zarate, Carlos A.
    NEUROPSYCHOPHARMACOLOGY, 2019, 44 (SUPPL 1) : 456 - 457
12345